ArticleVaccines2024

Pharmacokinetic and Environmental Risk Assessment of Prime-2-CoV, a Non-Replicating Orf Virus-Based Vaccine against SARS-CoV-2.

Carina Metz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.